DGAP-News: Change in the Supervisory Board of MeVis Medical Solutions AG
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Change of
Personnel
Change in the Supervisory Board of MeVis Medical Solutions AG
20.06.2011 / 16:57
---------------------------------------------------------------------
Bremen, June 20, 2011 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a
leading software company in medical imaging, today announced a change in
their Supervisory Board.
Mr. Peter Kuhlmann-Lehmkuhle, Managing Partner of C. Melchers GmbH&Co.
KG, was elected to the Supervisory Board in the company's Annual General
Meeting on June 15, 2011. Simultaneously, the previous Supervisory Board
Members Prof. Dr. Heinz-Otto Peitgen and Dr. Jens Kruse were elected to the
company's control panel. Mr. Kuhlmann-Lehmkuhle is replacing the former
Supervisory Board member Dr. Peter Zencke, who has not been available for a
new term.
'With Peter Kuhlmann-Lehmkuhle, we have gained an experienced and
successful Bremen entrepreneur for our Supervisory Board. Being a pre-IPO
shareholder he certainly will shape our future business development.
Therefore, we look forward to working with him', says Dr. Carl. J. G.
Evertsz, chairman of the MeVis Medical Solutions AG Executive Board.
Furthermore, the Executive and Supervisory Board both expressed their
gratitude to Dr. Peter Zencke, who will be available to the company as an
external consultant.
In the Supervisory Board Meeting held on June 15, 2011, Prof. Dr. Peitgen
was elected as Chairman of the Supervisory Board and Dr. Jens Kruse as his
Deputy.
For further information please visit http://www.mevis.de.
MeVis Medical Solutions AG was founded in 1997 and is one of the world's
leading independent manufacturers and vendors of medical imaging software
with focus on dedicated, disease-oriented clinical applications. Over the
past few years, there has been an enormous increase in the complexity and
volume of medical imaging data derived from digital imaging processes such
as computed tomography (CT), magnetic resonance imaging (MRI), and
ultrasound (US). MeVis Group's products analyze and process this data in
such a way as to provide medical professionals with crucial information for
early detection, diagnosis and intervention in the areas of cancer and lung
diseases as well as neurological conditions. The Group develops its
software solutions in close consultation with the world's leading medical
experts and original equipment makers in the medical technology sector and
primarily markets this software via these partnerships.
************************************************************************
Corporate Contact:End of Corporate News
MeVis Medical Solutions AG
Dr. Kai Holtmann
Investor Relations Manager
Tel:
+49 421 22495-63
E-mail: kai.holtmann(at)mevis.de
---------------------------------------------------------------------
20.06.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AGUniversitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 224 95 0
Fax: +49 421 224 95 11
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
129190 20.06.2011Unternehmensinformation / Kurzprofil:
Datum: 20.06.2011 - 16:57 Uhr
Sprache: Deutsch
News-ID 34432
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 442 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Change in the Supervisory Board of MeVis Medical Solutions AG"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
